Hypoglycaemia Clinical Trials

14 recruiting

Frequently Asked Questions

Common questions about Hypoglycaemia clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting

Gastric emptying and hormonal changes in idiopathic reactive hypoglycaemia following a mashed potato meal

idiopathic reactive hypoglycaemia
The University of Adelaide40 enrolled1 locationACTRN12621001711808
Recruiting
Phase 3

The C*STEROID Trial: Corticosteroids before planned caesarean section from 35+0 to 39+6 weeks of pregnancy.

Transient tachypnoea of the newbornNeonatal hypoglycaemiaCaesarean section delivery+1 more
The University of Auckland2,548 enrolled23 locationsACTRN12620000914965
Recruiting
Phase 2

A multi-centre trial of a new immunosuppression regime for pancreatic islet transplant recipients

Hypoglycaemia UnawarenessIslet graft survivalType 1 Diabetes
The University of Sydney15 enrolled3 locationsACTRN12619000268145
Recruiting
Phase 4

Treating hypoglycaemia in newborns with Glucagon And Diazoxide: The Glad Study

HypoglycaemiaInfant of diabetic mother
Dr Lydia Kennedy100 enrolled1 locationACTRN12617001473358
Recruiting

Preventing the neurotoxic effects of hypoglycaemia in adolescents with Type 1 diabetes- a randomised placebo-controlled trial

Hypoglycaemia
Murdoch Childrens Research Institute10 enrolled1 locationACTRN12617000780358
Recruiting
Phase 4

Comparison of the incidence and duration of hypoglycaemia assessed by Continuous Glucose Monitoring (CGM) in elderly type 2 Diabetes patients treated with two different insulin regimens (long and short acting insulin VS premixed insulin) .

Type two Diabetes MellitusHypoglycaemia in elderly type two Diabetes Mellitus patients on premixed insulin treatment
Western Sydney Local Health District84 enrolled2 locationsACTRN12616001158459
Recruiting
Phase 2

The effects of Glucagon-Like Peptide 1 on gastric emptying in healthy volunteers with normal or low blood glucose levels

Gastric emptying in the context of supraphysiologic Glucagon-Like Peptide-1 and hypoglycaemia
Dr Mark Plummer10 enrolled1 locationACTRN12611000973910
Recruiting
Phase 4

The Low Glucose Suspend Trial - Comparing insulin pump therapy with low glucose suspend feature versus standard insulin pump therapy in patients with type 1 diabetes with hypoglycaemia unawareness

Type 1 diabetes Hypoglycaemia unawareness
Princess Margaret Hospital for Children100 enrolled1 locationACTRN12610000024044